Wealth Enhancement Advisory Services LLC Has $29.91 Million Stock Position in Rocket Lab Corporation $RKLB

Key Points

• Wealth Enhancement Advisory Services LLC increased its stake in Rocket Lab by 139.3% in Q4 to 428,717 shares, worth about $29.91 million (≈0.08% of the company).
• Insider selling and dilution concerns: company insiders sold 1,807,614 shares (~$136.3M) over the past three months, and a proposed $1B at‑the‑market/forward equity program has revived market worries about share overhang.
• Market and analyst context: institutional investors own ~71.8% of RKLB, analysts' consensus is a "Moderate Buy" with median targets in the mid‑$80s to $100+ range, while the stock trades near ~$66 with a market cap of about $37.5B.

Wealth Enhancement Advisory Services LLC boosted its holdings in Rocket Lab Corporation (NASDAQ:RKLB - Free Report) by 139.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 428,717 shares of the rocket manufacturer's stock after buying an additional 249,577 shares during the period. Wealth Enhancement Advisory Services LLC owned approximately 0.08% of Rocket Lab worth $29,907,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Wilmington Savings Fund Society FSB bought a new position in shares of Rocket Lab during the 3rd quarter worth about $25,000. Hara Capital LLC bought a new stake in Rocket Lab in the third quarter valued at about $25,000. Aventura Private Wealth LLC acquired a new position in Rocket Lab in the fourth quarter worth about $25,000. UMB Bank n.a. boosted its holdings in Rocket Lab by 352.5% during the third quarter. UMB Bank n.a. now owns 543 shares of the rocket manufacturer's stock valued at $26,000 after purchasing an additional 423 shares in the last quarter. Finally, Sound Income Strategies LLC bought a new stake in shares of Rocket Lab in the 3rd quarter valued at approximately $27,000. 71.78% of the stock is currently owned by institutional investors and hedge funds.

Rocket Lab Trading Down 2.8%

RKLB stock opened at $66.07 on Wednesday. The business has a fifty day moving average price of $75.50 and a 200 day moving average price of $64.26. The company has a debt-to-equity ratio of 0.10, a current ratio of 4.08 and a quick ratio of 3.61. Rocket Lab Corporation has a fifty-two week low of $14.71 and a fifty-two week high of $99.58. The stock has a market capitalization of $37.49 billion, a price-to-earnings ratio of -178.56 and a beta of 2.20.

Key Stories Impacting Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Operational wins: Rocket Lab completed its 84th Electron launch and announced a record $190M hypersonic block‑buy for 20 HASTE test flights, which boost revenue visibility and backlog conversion potential. What's Going On With Rocket Lab Stock Monday?
• Positive Sentiment: Analyst optimism and upside: Multiple broker targets imply material upside (median targets in the mid‑$80s to $100+ range) and some analysts see ~30%+ upside based on growth in launches, government contracts and space systems. Rocket Lab (RKLB) Stock Could Surge 30%+ — What Analysts Are Betting On
• Positive Sentiment: New coverage: Clear Street initiated coverage with a Buy and an $88 price target, highlighting Neutron and management execution as catalysts. Institutional interest and raised targets support medium‑term bullishness. Clear Street Initiates Coverage on Rocket Lab Corporation (RKLB) with a Buy
• Neutral Sentiment: Sector tailwinds: Broader space-stock enthusiasm (SpaceX IPO hopes, rising defense budgets) is lifting RKLB sentiment, but benefits are sector‑wide rather than company‑specific. Is 2026 the Year of Space Stocks? 2 Stocks to Watch
• Neutral Sentiment: Capital raise framing: Some analysts (e.g., Seeking Alpha) argue the company’s $1B forward equity program is opportunistic and minimizes immediate dilution, positioning RKLB for M&A and growth funding. That interpretation reduces near‑term panic but doesn’t eliminate dilution risk. Rocket Lab: This $1B Capital Raise Is More Bullish Than You Think
• Negative Sentiment: Dilution concerns: Coverage and market posts highlight a new $1B ATM/forward sales agreement and forward sale mechanics that can create share overhang; that headline has been the main near‑term sell pressure. Rocket Lab shares slide as $1B at-the-market equity program revives dilution concerns
• Negative Sentiment: Insider selling: Public filings and data show extensive insider sales in recent months, which can weigh on sentiment even if sales are for diversification/liquidity reasons. Rocket Lab shares slide as $1B at-the-market equity program revives dilution concerns

Insiders Place Their Bets

In other Rocket Lab news, Director Merline Saintil sold 96,000 shares of the firm's stock in a transaction dated Tuesday, January 13th. The shares were sold at an average price of $86.58, for a total value of $8,311,680.00. Following the completion of the sale, the director owned 292,529 shares in the company, valued at approximately $25,327,160.82. This trade represents a 24.71% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Peter Beck sold 18,857 shares of the business's stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $69.59, for a total transaction of $1,312,258.63. Following the completion of the transaction, the chief executive officer directly owned 884,085 shares of the company's stock, valued at approximately $61,523,475.15. This represents a 2.09% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 1,807,614 shares of company stock valued at $136,326,621 over the last three months. Company insiders own 11.90% of the company's stock.

Analyst Ratings Changes

Several equities analysts recently commented on the company. TD Cowen restated a "buy" rating on shares of Rocket Lab in a research report on Thursday, January 22nd. Clear Str raised Rocket Lab to a "strong-buy" rating in a report on Wednesday, March 18th. Stifel Nicolaus boosted their target price on shares of Rocket Lab from $75.00 to $85.00 and gave the company a "buy" rating in a research note on Monday, December 22nd. KeyCorp lowered shares of Rocket Lab from an "overweight" rating to a "sector weight" rating in a report on Thursday, January 15th. Finally, Needham & Company LLC dropped their target price on shares of Rocket Lab from $110.00 to $95.00 and set a "buy" rating for the company in a research report on Friday, February 27th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $75.92.

Rocket Lab Company Profile

Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company's primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company's propulsion capabilities.

Want to see what other hedge funds are holding RKLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rocket Lab Corporation (NASDAQ:RKLB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.